01.09.2017 • Product

Kolb and Stockmeier Chemie tighten partnership for distribution of nonionic surfactants in Germany

Photo

Since October 2016, Stockmeier Chemie represents the surfactant portfolio of Kolb as its partner in Germany. After 10 months of successful business development the partnership is now made official by a contract signed by both parties. The portfolio comprises products of Kolb in Hedingen in Switzerland and Moerdijk in the Netherlands.

"We’ve been working closely with the Stockmeier Group for a long time already, and we are confident that this strategic partnership will enhance our market presence and serve as a high-quality distribution channel,” says Dr. Anja Vonderhagen, Business Director of Kolb.

Brands such as Kotilen, Imbentin, Sympatens and Greenbentin have set standards in the cosmetics and cleaning segments and in several other industries. Dirk Seidel, General Manager for Specialty Chemicals at Stockmeier Chemie: "Kolb has evolved into a key partner for the Stockmeier Group, especially with its focus on Europe. Oleochemical products that are certified as sustainable will define the future in many areas of application. That makes this cooperation an important building block for the future orientation of our sales activities."

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.